-
Mashup Score: 67Meeting of the Oncologic Drugs Advisory Committee - 10 day(s) ago
April 12, 2024 Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 67Meeting of the Oncologic Drugs Advisory Committee - 11 day(s) ago
April 12, 2024 Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 67Meeting of the Oncologic Drugs Advisory Committee - 14 day(s) ago
April 12, 2024 Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 67Meeting of the Oncologic Drugs Advisory Committee - 14 day(s) ago
April 12, 2024 Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 67Meeting of the Oncologic Drugs Advisory Committee - 15 day(s) ago
April 12, 2024 Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 61Meeting of the Oncologic Drugs Advisory Committee - 1 month(s) ago
April 12, 2024 Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
An FDA advisory committee voted 12-2 that the benefits of the investigational therapy imetelstat outweigh the risks for the treatment of transfusion-dependent anemia in certain adults with myelodysplastic syndromes.Results of a phase 3 trial provided by the manufacturer for a new drug application showed imetelstat (Geron Corporation) — a telomerase inhibitor — conferred a significant
Source: www.healio.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 7
March 15, 2024: Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 7
March 15, 2024: Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
March 15, 2024: Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
FDA Oncologic Drugs Advisory Committee to meet April 12 to discuss the use of minimal residual disease as an endpoint in multiple myeloma clinical trials to support accelerated approval of a new product or a new indication. https://t.co/tQ4JxoyI4y #FDAODAC